Fariba Sarem and Colleagues Share Study About FAM132B Gene Expression in Beta-Thalassemia
Fariba Sarem, International Affairs expert at Iranian Blood Transfusion Organization, posted on LinkedIn:
“Excited to announce the publication of my latest research in the International Journal of Hematology-Oncology and Stem Cell Research.
Title: Expression of the FAM132B Gene in Iranian Patients with Beta-Thalassemia
This study investigates the expression of the FAM132B gene, which encodes erythroferrone (ERFE), a key regulator of iron homeostasis, in Iranian patients with beta-thalassemia major (BTM) and intermedia (BTI).
Using SYBR Green-based real-time PCR (RT-PCR), we analyzed gene expression in 40 thalassemia patients and 20 healthy controls. Our findings revealed:
- Upregulation of FAM132B in BTI patients compared to BTM (p = 0.0151).
- No significant difference between thalassemia patients (BTM & BTI) and healthy controls.
These results highlight differential ERFE expression across thalassemia subtypes and suggest the need for further research into its potential as a therapeutic target.
Grateful to my collaborators and mentors for their support throughout this project.”
Title: Expression of the FAM132B Gene in Iranian Patients with Beta-Thalassemia
Authors: Fariba Sarem, Azita Azarkeivan, Ahmad Mardani, Majid Shahabi

Read full paper here.
Stay informed with Hemostasis Today.
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia
